WO2021041591A1
|
|
Compositions and methods of treating vascular diseases
|
WO2021041592A1
|
|
Methods of treating vascular diseases
|
US2019282622A1
|
|
Modalities for the treatment of degenerative diseases of the retina
|
AU2016250484A1
|
|
Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogammed cells
|
AU2016250412A1
|
|
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
|
CA2995977A1
|
|
Clinical formulations
|
KR20180011761A
|
|
An improved assay for the efficacy of human retinal pigment epithelial (RPE) cells and photoreceptor precursor cells
|
SG11201701709YA
|
|
Retinal ganglion cells and progenitors thereof
|
AU2015201435A1
|
|
Improved methods of producing RPE cells and compositions of RPE cells
|
AU2014203668A1
|
|
Highly efficient methods for reprogramming differentiated cells and for generating animals and embryonic stem cells from reprogammed cells
|
AU2014233403A1
|
|
Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
|
AU2014201421A1
|
|
Derivation of Embryonic Stem Cells and Embryo-Derived Cells
|
AU2013267025A1
|
|
Improved modalities for the treatment of degenerative diseases of the retina
|
AU2013201444A1
|
|
Hemangio-colony forming cells
|
EP2788472A2
|
|
Method of directed differentiation producing corneal endothelial cells
|
AU2012201562A1
|
|
Improved modalities for the treatment of degenerative diseases of the retina
|
AU2011280878B2
|
|
Methods for detection of rare subpopulations of cells and highly purified compositions of cells
|
EP3441462A1
|
|
Hemangio colony forming cells and non-engrafting hemangio cells
|
EP2302034A2
|
|
Improved methods of reprogramming animal somatic cells
|